Tiam Mana Saffari

183 STEM CELLS, VASCULARITY, AND NERVE 8 72. Chen Y-T, Sun C-K, Lin Y-C, et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Journal of translational medicine. 2011;9(1):51. 73. Faroni A, Smith RJ, Lu L, Reid AJ. Human Schwann‐like cells derived from adipose‐derived mesenchymal stem cells rapidly de‐differentiate in the absence of stimulating medium. European Journal of Neuroscience. 2016;43(3):417-430. 74. Dong R, Liu Y, Yang Y, Wang H, Xu Y, Zhang Z. MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy. BioMed research international. 2019;2019. 75. Sowa Y, Kishida T, Imura T, et al. Adipose-derived stem cells promote peripheral nerve regeneration in vivo without differentiation into Schwann-like lineage. Plastic and reconstructive surgery. 2016;137(2):318e-330e. 76. Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annual review of physiology. 2015;77:13-27. 77. Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14(3):5338-5366. 78. Rezaie J, Ajezi S, Avci CB, et al. Exosomes and their Application in Biomedical Field: Difficulties and Advantages. Mol Neurobiol. 2018;55(4):3372-3393. 79. Blanc L, Vidal M. New insights into the function of Rab GTPases in the context of exosomal secretion. Small GTPases. 2018;9(1-2):95-106. 80. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789. 81. Liu CY, Yin G, Sun YD, et al. Effect of exosomes fromadipose‐derived stem cells on the apoptosis of Schwann cells in peripheral nerve injury. CNS Neuroscience & Therapeutics. 2020;26(2):189-196. 82. Gong M, Yu B, Wang J, et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017;8(28):45200. 83. Qing L, Chen H, Tang J, Jia X. Exosomes and their MicroRNA cargo: newplayers in peripheral nerve regeneration. Neurorehabilitation and neural repair. 2018;32(9):765-776. 84. Qi J, Liu Q, Reisdorf RL, et al. Characterization of a purified exosome product and its effects on canine flexor tenocyte biology. Journal of Orthopaedic Research®. 2020. 85. Wang Y, Li Z-w, Luo M, Li Y-j, Zhang K-q. Biological conduits combining bone marrow mesenchymal stem cells and extracellular matrix to treat long-segment sciatic nerve defects. Neural regeneration research. 2015;10(6):965. 86. F Lévesque M, Neuman T, Rezak M. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson’s disease: five-year post-operative outcome. The Open Stem Cell Journal. 2009;1(1). 87. Faroni A, Mobasseri SA, KinghamPJ, ReidAJ. Peripheral nerve regeneration: experimental strategies and future perspectives. Adv Drug Deliv Rev. 2015;82-83:160-167. 88. Zhao Z, Wang Y, Peng J, et al. Repair of nerve defect with acellular nerve graft supplemented by bone marrow stromal cells in mice. Microsurgery. 2011;31(5):388-394.